Reconstructive surgery of the operated stomach

2019 ◽  
Author(s):  
Дмитрий Ручкин ◽  
Dmitriy Ruchkin ◽  
Валентин Козлов ◽  
Valentin Kozlov
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Gastrointestinal Tract ◽  
Medical Research ◽  
Reconstructive Surgery ◽  
Gastric Surgery ◽  
Long Term Results ◽  
National Medical ◽  
Operated Stomach

The monograph formulated the concept of physiological reconstruction of the digestive tract during repeated operations on the stomach. The experience of surgical treatment of patients with diseases of the operated stomach and recurrent gastric cancer of the Department of reconstructive surgery of the esophagus and stomach Of the national medical research center of surgery named after A. V. Vishnevsky is presented. The immediate and long-term results of the original operations selected individually are highlighted. Special attention is paid to the study of motor and evacuation function of the gastrointestinal tract, to identify the frequency and severity of postgastrectomy and postgastresection syndromes after reconstructive interventions. For students and teachers, as well as anyone interested in the problems of gastric surgery.

scholarly journals Immediate and Long-Term Results of the Spleen-Preserved Operations in the Surgical Treatment of Gastric Cancer

2020 ◽  
Vol 13 (3) ◽  
pp. 227-232
Author(s):  
Marina I. Rogozianskaia ◽  
Alexander Nikolayevich Redkin ◽  
Ivan Petrovich Moshurov
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Total Gastrectomy ◽  
The Body ◽  
Long Term Results ◽  
D2 Lymphadenectomy ◽  
Spleen Preserving ◽  
Cardiac Region ◽  
Clinically Significant

ntroduction. Currently, total gastrectomy with D2 lymphadenectomy is the standard surgical treatment for proximal gastric cancer at the resectable stages (I-III). The issue of advisability of splenectomy as a component of lymphadenectomy remains a controversial one, especially when the tumor is localized in the region of the body or cardiac region of the stomach.The aim of the study was to compare immediate and long-term outcomes, including the quality of life, between spleen preserving and spleen removing surgeries.Methods. The study included 363 patients with gastric cancer II-III stages, localized in the upper and/or the middle third of the stomach, who underwent surgery at the Voronezh Regional Clinical Oncology Hospital and the Voronezh Clinical Hospital of the Russian Railway-Medicine in 2015-2017. All patients were conditionally divided into 2 groups for comparative retrospective analysis. All patients of the first (experimental or spleen-preserved) group (144 patients) were performed R0 total gastrectomy with D2 lymphadenectomy, including splenic hilar nodes (№ 10,11) removal without splenectomy. Patients of the second (control or splenectomy) group (219 patients) were performed R0 total gastrectomy with D2 lymphadenectomy and prophylactic splenectomy (for splenic hilar nodes removal).Results. The average duration of the operation and the volume of blood loss did not differ in both groups. The incidence of early postoperative surgical complications was lower in the spleen-preserved group. Splenectomy was associated with more severe complications of class 4 and 5 according to the Clavien-Dindo classification. Conclusion. Parameters of the 1- and 3-year overall survival rate did not differ in both groups. The results of the GSRS questionnaire were similar in both groups, excluding reflux-esophageal symptoms scale. The reflux scale demonstrated a statistically and clinically significant advantage of spleen preservation.

Long-term results of surgical treatment of gastric cancer

1986 ◽  
Vol 67 (2) ◽  
pp. 104-106
Author(s):  
A. S. Abdullin ◽  
F. Sh. Akhmetzyanov ◽  
A. A. Samigullin ◽  
Z. N. Shemeunova ◽  
V. A. Arinin ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Stomach Cancer ◽  
Stage Iv ◽  
Stage Ii ◽  
Stage Iii ◽  
Disease Stage ◽  
Long Term Results ◽  
Long Term Outcomes

We analyzed long-term outcomes of the treatment of 217 patients (men - 126, women - 91), who underwent radical operations for stomach cancer in the period of 1972 till 1976. 14 patients were under 39, 52 - from 40 to 49, 50 to 59 - 52, 60 to 69 - 80, over 70 years old - 19. The youngest patient was 28 years old and the oldest - 76 years old. Most patients (185) were operated on at stage III of the disease, stage II was diagnosed in 27 patients, and stage IV - in 5 patients.

scholarly journals Therapy intensification in high-risk neuroblastoma patients with poor response to standard induction: experience of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology

2019 ◽  
Vol 18 (4) ◽  
pp. 19-28
Author(s):  
T. V. Shamanskaya ◽  
D. Y. Kachanov ◽  
A. V. Dumacheva ◽  
M. V. Teleshova ◽  
D. V. Shevtcov ◽  
...  
Keyword(s):  
High Risk ◽  
Medical Research ◽  
Induction Therapy ◽  
Poor Response ◽  
Research Center ◽  
Long Term Results ◽  
Type I ◽  
Pediatric Hematology ◽  
National Medical

High-risk neuroblastoma (NB) is characterized by unsatisfactory treatment results and low probability of long-term survival despite the multimodal therapeutic approach (chemotherapy, surgical treatment, radiation therapy, autologous hematopoietic stem cell transplantation, etc.). One of the prognostic factors in this cohort of patients is the response to induction therapy. The article presents the experience of the intensification of induction therapy in 12 patients with high-risk NB with a poor response (mixed response, stable disease) to standard induction therapy who received treatment at Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, assessing its impact on the prognosis of the disease. The study was approved by the Independent Ethics Committee of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Patients received an additional two courses of chemotherapy with the inclusion of a type I topoisomerase inhibitor topotecan (TCE – topotecan, cyclophosphamide, etoposide). This regimen of intensification of therapy has demonstrated its feasibility. The main grade 3–4 toxicity was hematologic. An improvement in response was achieved in 5/12 (41.6%) patients. However, long-term results of therapy remained unsatisfactory. The 3-year EFS was 16.7% (95% CI 0.0–37.8), the 3-year OS was 50.0% (95% CI 21.7–78.3). Thus, the intensification of therapy in patients with high-risk NB with a poor response to standard induction therapy did not improve treatment outcomes.

scholarly journals Complex treatment of patients with achalasia of cardia and cardiospasm subject to psychosomatic disorders.

2018 ◽  
Vol 96 (5) ◽  
pp. 419-426
Author(s):  
A. F. Chernousov ◽  
T. V. Khorobrykh ◽  
F. P. Vetshev ◽  
L. V. Romasenko ◽  
V. A. Dulova ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Gastrointestinal Tract ◽  
Neuromuscular Diseases ◽  
Long Term Results ◽  
Complex Treatment ◽  
Psychosomatic Disorders ◽  
Main Method ◽  
All Diseases

Achalasia of cardia and cardiospasm are neuromuscular diseases characterized by functional disorders of the permeability of the esophageal-gastric junction, their prevalence is up to 22% of all diseases of the esophagus. The article presents a series of clinical studies of 114 patients with achalasia of cardia and cardiospasm since 2006. A modified algorithm for the examination and treatment ofpatients with different stages of the disease is presented. The balloon cardiodilation, as the main method of treatment, was carried out by 76 patients. Surgical treatment was performed in 36 patients: 17 patients with stage III performed esophagocardiomyotomy with incomplete fundoplication in the modification of A.F. Chernousov, 19 - with the IV stage transhiatal extirpation of the esophagus with gastroplasty was performed. A group of 26 patients with psychosomatic disorders was selected, who, in addition to traditional surgical treatment, underwent psychotropic therapy. Good immediate and long-term results of complex treatment were obtained. Substantially faster relief of symptoms of dysphagia and other complaintsfrom the gastrointestinal tract was noted, a more persistent and prolonged effect of dilation sessions and a significant improvement in the quality of life compared with patients who did not receive psychotropic drugs. In this group of patients, we did not observe any recurrence of the disease after the dilatation sessions. The control examination (endoscopic and X-ray examination of the upper gastrointestinal tract, manometry) revealed no signs of dysphagia or gastroesophageal reflux in any patient, including among the operated.

scholarly journals Epidemiology and Surgical Treatment of Gastric Cancer in Latvia

2009 ◽  
Vol 63 (4-5) ◽  
pp. 249-252
Author(s):  
Armands Sīviņš ◽  
Jānis Misiņš ◽  
Corrado Pedrazzani ◽  
Guntis Ancāns ◽  
Aivars Stengrēvics ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Long Term Results ◽  
R0 Resection ◽  
Curative Intent ◽  
Operative Complications ◽  
Short And Long Term ◽  
Oncology Centre ◽  
Histopathologic Confirmation

Epidemiology and Surgical Treatment of Gastric Cancer in Latvia The aim of the study was to evaluate short- and long-term results of surgical treatment of gastric cancer performed in Latvia Oncology Centre. Retrospectively data was collected from 461 patients who underwent gastrectomy with curative intent in the Latvia Oncology Centre from January 2001 to December 2005. The data was subjected to statistical analysis. On average, 92.2 (range 81-102) R0-R1 gastrectomies were performed each year. Post-operative complications occurred in 75 patients (16.3%); in-hospital mortality was 3.3%. The overall 5-year survival was 50.8%. In 444 cases (96.3%) there was histopathologic confirmation of R0-resection with a 5-year survival of 52.5% (P < 0.001). Considering pT category, 5-year survival (median) was 88.6% (not reached) for pT1 patients, 65% (not reached) for pT2, 42.3% (35.7 months) for pT3 and 27% (14.2 months) for pT4 (P < 0.001). Considering the pN category, 5-year survival (median) was 67% (not reached) for pN0 patients, 30% (22.1 months) for pN1 and 29% (14.2 months) for pN2-3 (P < 0.001). Short- as well as long-term results are comparable with Western experiences, but not for pN+ patients where no difference between pN1 and pN2 cases was observed.

“Complex” hepatic echinococcosis

2021 ◽  
Vol 26 (4) ◽  
pp. 32-40
Author(s):  
A. B. Goncharov ◽  
Y. A. Kovalenko ◽  
Kh. A. Ayvazyan ◽  
R. Z. Ikramov ◽  
L. A. Marinova ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Lung Damage ◽  
Long Term Results ◽  
Tubular Structures ◽  
National Medical ◽  
Laparoscopic Intervention ◽  
Hepatic Echinococcosis ◽  
Isolated Liver ◽  
Observation Period

Aim. To study the long-term results of surgical treatment in patients with “complex” hepatic echinococcosis.Materials and methods. The results of surgical treatment of 118 patients with hepatic echinococcosis from 2015 to 2020 at the A.V. Vishnevsky National Medical Research Center of Surgery were analyzed. The term “complex” hepatic echinococcosis has been proposed. A comparative analysis of the number and type of complications and surgical interferences 2 groups of patients was carried out: 66 patients with hepatic echinococcosis, 52 patients with complex hepatic echinococcosis.Results. During the observation period, no any recurrence was recorded. 55 (44%) of 118 patients had complex hepatic echinococcosis. Isolated liver damage was found in 74% of cases, combined liver and lung damage in 20% cases and with other organs – in 6%. In most cases, pericystectomy was performed (82%), 8% of patients underwent atypical hepatectomy, 4% – segmental resection, 3% – laparoscopic intervention, 3% – hemihepatectomy. Postoperative complications were recorded in 22 (18,6%) of cases. Accumulations of bile and biliary fistulas formed in 45% of cases, pneumotothorax or hydrothorax – in 23%, wound abscess – in 18%, hematomas in the hepatectomy zone – in 14% of the cases.Conclusion. Surgical treatment of complex hepatic echinococcosis requires an individual approach to the choice of the operation option. Preference should be given to parenchyma-preserving radical operations. When the liver lobe is totally replaced with a hydatid cyst and in case of cystobiliary fistulas hemihepatectomy should be performed, and it is acceptable to leave the fibrous capsule on large tubular structures.

6582 Long-term results of surgical treatment of recurrent gastric cancer

2009 ◽  
Vol 7 (2) ◽  
pp. 385
Author(s):  
M. Khudayberdieva ◽  
M. Djuraev ◽  
S. Mirzaraimova ◽  
D. Egamberdiev
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Long Term Results ◽  
Recurrent Gastric Cancer

scholarly journals Evaluation of surgical treatment for advanced gastric cancer based on long term results.

1989 ◽  
Vol 22 (10) ◽  
pp. 2494-2497
Author(s):  
Kiwao ISHIMOTO ◽  
Hiroshi TANIMURA ◽  
Yoji TABUSE ◽  
Yugo NAGAI ◽  
Katsuyoshi TABUSE ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Advanced Gastric Cancer ◽  
Long Term Results

Long term results with the surgical treatment of resectable gastric cancer

1999 ◽  
Vol 35 ◽  
pp. S149
Author(s):  
J.B. Guimarães dos Santos ◽  
Hernani Silva ◽  
Dora Cunha ◽  
Lúcio Santos ◽  
J.P. Guerra ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Long Term Results ◽  
Resectable Gastric Cancer

Gastric Cancer in Elderly Patients. Long Term Results of Surgical Treatment

2013 ◽  
Vol 24 ◽  
pp. iv65
Author(s):  
César Benito Fernández ◽  
Juan José Arenal Vera ◽  
Manuel González Sagrado ◽  
Miguel Angel Citores Pascual ◽  
Claudia Tinoco Carrasco
Keyword(s):  
Gastric Cancer ◽  
Surgical Treatment ◽  
Elderly Patients ◽  
Long Term Results
Sign in / Sign up

Export Citation Format

Share Document